Abstract:Key Points A large proportion of genomic variation might be associated with human disease phenotypes. New approaches should improve our understanding of this variation and its functional significance. Because there is insufficient guidance for molecular epidemiologists to optimally select variants for an epidemiology study, methods that prioritize the choice of genetic variants need to be included in molecular epidemiological studies. Laboratory-based evidence about the functional significance of a genetic variant can provide the strongest evidence for the functional role of a genetic variant, but these studies are difficult to mount on the scale that may be required for characterizing all human genetic variants, and their results might not always reflect in vivo genotype function in humans. Novel approaches to assessing the function of genetic variants are required to provide molecular epidemiological association studies with the information that is required to choose candidate genes and variants in these genes for association studies, and to optimally interpret the results of observed associations. Novel experimental approaches that might be informative, include the HaploCHIP method, gene tagging, gene trapping, N -ethyl- N -nitrosourea (ENU) mutagenesis, proteomics methods and evaluation of epigenetic mechanisms that assess genotype function. Non-laboratory-based approaches for assessing SNP function should also be considered. These approaches include those that use evolutionary similarity or structural effects of genetic variants, such as those implemented in the SIFT, PolyPhen or CODDLE algorithms. Population and evolutionary genetics data can be directly incorporated into association studies to optimize the identification of genes that are causally related to disease risk. The 'set association' approach is one example of this method. We propose an algorithm that can be useful in determining when a genetic variant might be functionally significant. This algorithm can be applied in the design and interpretation of molecular epidemiological association studies to maximize the potential that truly causative associations can be identified.

Guidelines for investigating causality of sequence variants in human disease

A brief history of human disease genetics

Capturing All Disease-Causing Mutations for Clinical and Research Use: Toward an Effortless System for the Human Variome Project

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Understanding genetic variants in context

Assessing the function of genetic variants in candidate gene association studies

Missing genetic diversity impacts variant prioritisation for rare disorders

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

Unique roles of rare variants in the genetics of complex diseases in humans

Characterizing the pathogenicity of genetic variants: the consequences of context

Genome-wide association studies: theoretical and practical concerns

Rare and low-frequency variants in human common diseases and other complex traits

Population Genetics of Rare Variants and Complex Diseases

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

From variant to function in human disease genetics

Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases

A Novel Method, the Variant Impact on Linkage Effect Test (VIOLET), Leads to Improved Identification of Causal Variants in Linkage Regions

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Rare coding variant analysis for human diseases across biobanks and ancestries

A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes

Genetic constraint at single amino acid resolution in protein domains improves missense variant prioritisation and gene discovery